Bupivacaine Hydrochloride With Dextrose Injection
FDA Label NDC 0264-9379

35 label sections · Submitted to the FDA by B. Braun Medical Inc. · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by B. Braun Medical Inc. for the product Bupivacaine Hydrochloride With Dextrose (NDC 0264-9379). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 important dosage and administration information, 2.2 recommended dosages of bupivacaine hydrochloride in dextrose injection, usp, 3 dosage forms and strengths, 4 contraindications, 5.1 use of spinal anesthetics during uterine contractions, 5.2 patients with hypertension, 5.3 dose-related toxicity, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

* Please review the disclaimer below.